Oncotype DX for colon cancer
Jump to navigation
Jump to search
Indications
- assessment of stage 1 or 2 colorectal carcinoma
Contraindications
- not appropriate for carcinoma in situ
- not appropriate for metastatic cancer
Specimen
- tissue from colorectal biopsy or surgical specimens
Procedure
Notes
- introduced in 2010
More general terms
Additional terms
References
- ↑ Gray RG, Quirke P, Handley K, et al. Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer J Clin Oncol. 2011; 29(32): PMID: https://www.ncbi.nlm.nih.gov/pubmed/22067390
- ↑ Clark-Langone KM, Sangli C, Krishnakumar J, Watson D. Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay. BMC Cancer. 2010 Dec 23;10:691 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21176237